Portland Global Advisors LLC purchased a new position in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 111,286 shares of the company’s stock, valued at approximately $4,710,000. Portland Global Advisors LLC owned approximately 1.37% of iShares Genomics Immunology and Healthcare ETF at the end of the most recent quarter.
Separately, Anchor Investment Management LLC purchased a new stake in iShares Genomics Immunology and Healthcare ETF during the 2nd quarter valued at approximately $98,000.
iShares Genomics Immunology and Healthcare ETF Price Performance
Shares of IDNA opened at $37.00 on Friday. The firm has a market cap of $312.65 million, a P/E ratio of 28.20 and a beta of 0.97. iShares Genomics Immunology and Healthcare ETF has a 1 year low of $25.82 and a 1 year high of $44.15. The company has a 50 day simple moving average of $41.17 and a two-hundred day simple moving average of $34.12.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
See Also
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding IDNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report).
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
